{"changes":[],"country":"FI","description":"Machine-learning platform that engineers N-terminal signal peptides to boost protein expression yield in mammalian systems. Sold to therapeutic developers working on biologics, mRNA, biosimilars, antibodies, and vaccines. Spun out of University of Helsinki research with a $5.7M raise and BioTools Innovator selection.","domain":"avenuebiosciences.com","employees":null,"founded":2023,"fundingTotalQuarantined":false,"githubOrg":null,"githubStars":null,"industry":"bio","investors":[],"lat":60.16662,"lng":24.943541,"location":"Helsinki, Finland","name":"Avenue Biosciences","rounds":[{"amountQuarantined":false,"amountUsd":2484000,"currency":"EUR","date":"2024-10-01","investors":[],"leadInvestor":null,"source":{"fact":"round","publisher":"eu-startups","retrievedAt":"2026-05-05","status":"attributed","url":null},"status":"attributed","type":"seed","url":null}],"slug":"avenuebiosciences-com","sources":[{"fact":"round","publisher":"eu-startups","retrievedAt":"2026-05-05","status":"attributed","url":null},{"fact":"existence","publisher":"avenuebiosciences.com","retrievedAt":"2026-05-05","status":"self-reported","url":"https://avenuebiosciences.com"},{"fact":"description","publisher":"avenuebiosciences.com","retrievedAt":"2026-05-05","status":"self-reported","url":"https://avenuebiosciences.com"}],"stage":"seed","techStack":["Cloudflare","Unpkg","Google Tag Manager","cdnjs","jquery 3.5.1"],"totalRaisedUsd":2484000,"updatedAt":"2026-05-05"}